MedTrace Logo

Cochlear Implantation in Adults With Asymmetric Hearing Loss Clinical Trial

NCT03052920 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-03-11

Study results available
· View outcomes & findings →

Summary

This longitudinal study evaluates the possible benefit of cochlear implantation in the poor ear of adults with asymmetric hearing loss who continue to use a hearing aid in the better hearing ear.

Conditions

Interventions

DEVICE

Cochlear implant

Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.

Sponsors & Collaborators

  • Midwest Ear Institute

    collaborator OTHER

  • House Clinic, Inc.

    collaborator INDUSTRY

  • NYU Langone Health

    collaborator OTHER

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Jill B Firszt, PhD · Washington University School of Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-28
Primary Completion
2020-11-17
Completion
2021-03-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03052920 on ClinicalTrials.gov